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Abstract
We report a case of primary clear cell sarcoma occurring in the humerus. A 20 year old girl was referred to our
hospital two years ago with painless swelling of the soft tissue surrounding the proximal right humerus. The
conventional radiographic image showed an ill-defined, aggressive, osteolytic lesion associated with a partial
cortical defect of the proximal right humerus. Magnetic resonance imaging found an irregularly shaped
extraosseous mass extending from the proximal shaft of the right humerus, penetrating through the destroyed
bone and invading the biceps brachii. After preoperative chemotherapy, a total tumor resection, internal fixation
and bone cement implantation were performed. Histological studies of the resected tumor found that fibrous
septa divided into well-defined nests and polygonal and fusiform cells with clear cytoplasm. Immunohistochemical
studies demonstrated strong positive cytoplasmic staining with S-100 and scattered positivity with HMB-45. These
findings led to a final, definitive diagnosis of clear cell sarcoma of the humerus. After routine postoperative
chemotherapy, a 2-year follow-up showed no metastasis. Our findings in this report point out that primary clear
cell sarcoma can originate from within the humerus and that limb salvage surgery can obtain a good result.
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Background
Clear cell sarcoma is a malignant soft tissue neoplasm
first described by Enzingerin 1965 [1]. It is rare,
accounting for less than 1% of soft tissue sarcomas. It is
even rarer occurring in bone. To our knowledge, only
six cases of primary clear cell sarcoma of the bone have
been reported in English literature [2-4], but none of
them presented that the neoplasm arose from the
humerus. This paper reports on a case of primary clear
cell sarcoma that arose from the right humerus of a 20-
year-old girl.
Case presentation
A 20-year-old girl was admitted to our hospital with
painless swelling in the proximal right humerus of 6
weeks’ duration.
Physical examination revealed a healthy well-devel-
oped girl with a tender, palpable, firm mass arising from
the proximal shaft of the right humerus. A conventional
radiographic image showed an ill-defined, aggressive,
osteolytic lesion associated with a partial cortical defect
in the proximal shaft of right humerus (Figure 1A).
There was no evidence of osteoid or chondroid matrix
within the lesion.
Magnetic resonance imaging (MRI) showed an irregu-
larly shaped extraosseous mass extending around the
right humerus through the destroyed bone and invading
the biceps brachii (Figure 1B, C). The lesion had similar
signal intensity to muscle on T1-weighted images and a
heterogeneous increase in signal intensity on T2-
weighted sequences. A CT-guided biopsy was per-
formed, and the specimen demonstrated atypical cells
and reactive new bone. Bone scintigraphy with 740 MBq
99mTc-HMDP showed no abnormal accumulation
other than in the proximal right humerus.
One week after preoperative chemotherapy, which
included cisplatin and adriamycin, a total tumor exci-
sion-alcoholization-replantation (EAR), internal fixation
and bone cement implantation were performed. With
the patient under general anesthesia; the anteriomedial
approach to the humerus which included the pathway
of CT-guided biopsy was used. After detachment of the
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involve the anteriomedial portion of the proximal
humerus and part of the biceps brachii. The site of cor-
tical destruction was not related to the attachment of
any tendon or ligament. The whole tumor was detached
from the bone and resected. (Figure 2) The humerus
was sawed completed through 3 cm distal from the dis-
tal end of tumor and a fast frozen biopsy was excised
from the periosteum at this site and the proximal end of
the tumor with no tumor cells found. The proximal end
of the humerus was slivered and the medullary canal
was scraped. To destroy all tumor cells that might be
remaining in the bone, we put the proximal humerus
into 95% ethanol for 30 min. Similar to Pezzillo’s
method, [5] we then implanted bone cement into the
medullary canal and fixed the humerus with a Limited
contact dynamic compressive plate (LC-DCP,
SYNTHES, Switzerland) (Figure 3).
Routine histopathological studies with hematoxylin-
eosin (HE), and immunohistochemical investigations
with S-100 and HMB-45 were performed. Histological
studies with HE showed fibrous septa divided into well-
d e f i n e dn e s t sa n dp o l y g o n a la n df u s i f o r mc e l l sw i t h
clear cytoplasm (Figure 4). Immunohistochemical stu-
dies demonstrated strong positive cytoplasmic staining
with S-100 and scattered positivity with HMB-45 (Figure
5). With the tumor displaying these morphological and
immunoenzymatic features, the neoplasm was diagnosed
as clear cell sarcoma
After the operation, the patient undertook routine
chemotherapy consisting of cisplatin, adriamycin and
methotrexate for 2 years. She has been followed up
every month and the humerus was found to be comple-
tely reconstructed one year after treatment. (Figure 6)
Discussion
Clear cell sarcoma, also known as malignant melanoma
of soft tissue, is a very rare soft tissue neoplasm which
comprises 1% of all musculoskeletal sarcomas. It is seen
Figure 1 A, Radiographs show an ill-defined, destructive,
osteolytic lesion of the right proximal humerus. B, C, D T1, T2
and axial view MR images show an irregularly shaped extraosseous
mass extending around the right humerus.
Figure 2 Gross pathology specimen of the excised tumor mass.
Bone and soft tissue margins were widely free of tumor. Figure 3 Radiograph after operation.
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ankle are the most common primary sites, accounting
for 33-43% of cases [6]. It usually presents as a slow-
growing mass. Pain and tenderness are the main symp-
toms in 33-50% of patients [7]. There is a slight female
predominance.
The gross appearance of clear cell sarcomas is usually
that of a lobular and well-bordered or encapsulated
lesion. Microscopically, the tumor in this case consisted
of well-defined nests separated by fibrous septa. The
tumor cells were polygonal or spindle-shaped and con-
tained eosinophilic or clear cytoplasm. The nuclei had
one or two large nucleoli. Some tumor cells may have
contained melanin pigment. Unlike clear cell chondro-
sarcoma, a rare subtype of chondrosarcoma, which pre-
sents clear cell chondrocytes, we found no clear cell
chondrocytes.
Immunohistochemically, the tumor cells of clear cell
sarcomas show strong staining with S-100 protein and
HMB-45. All these histological and immunohistochem-
ical features were present in our case. Because the
search for metastasis revealed no lesion other than that
in the right humerus, we feel that this case represents
the extremely rare event of a clear cell sarcoma arising
in bone.
Primary clear cell sarcoma and metastatic malignant
melanoma represent similar histopathological features.
Recent cytogenetic studies have shown that clear cell
sarcoma has a t(12;22) (q13;q12) translocation, a fea-
ture not encountered in malignant melanoma [8,9].
This chromosomal translocation of clear cell sarcoma
has been detected in 50-75% of patients [10]. Cytoge-
netic analysis was performed in only one of the six
previously presented cases of primary clear cell sar-
coma of bone and no chromosomal abnormality was
detected in that case [11]. We performed cytogenetic
analysis and also found no evidence of chromosomal
translocation.
The survival rates and metastatic incidence of primary
clear cell sarcoma of the bone are unknown because of
the limited number of cases reported. The longest survi-
val time of 65 months was reported by Yokoyama et al
[2]. Since, at the time our case presented 2 years ago,
no specific chemotherapy medicine had been known to
treat clear cell sarcoma, we used a routine chemother-
apy commonly employed in the case of osteosarcoma
including cisplatin, adriamycin and methotrexate. Our
patient now has been followed up for two years after
the operation, the adjunctive chemotherapy was finished
and there have been no findings of metastasis.
Figure 4 HE stained photomicrographs showed fibrous septa
divided into well-defined nests and polygonal and fusiform
cells with clear cytoplasm(×200).
Figure 5 Immunohistochemistry shows strongly positive
immunoreactivity for S-100 protein (×400) (A) and HMB-45
(×400) (B).
Figure 6 Radiographs at one year and 28 months after
operation.
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that this is a very malignant tumor, that she should
have an amputation at the shoulder. However, the
patient and her family wanted her to keep the limb.
Therefore, we decided to do a limb salvage operation.
We didn’t use tumour prosthesis or osteoarticular allo-
graft because the patient wanted to keep the function of
her shoulder joint and we found the joint to be normal.
As we have used EAR to treat osteosarcoma for many
years, and the results were satisfactory[12], we per-
formed a total tumor resection, alcoholization, replanta-
tion, internal fixation and bone cement implantation.
The effects of the operation and chemotherapy seem
to have been effective, so far, in eradicating the clear
cell sarcoma. The patient now feels no discomfort in
her right humerus and has no sign of metastasis. We
ordered the patient to come in for follow-up every
month. Our hope is that this case can be an example of
a good outcome of treatment for primary clear cell sar-
coma of the bone. We will continue follow up
indefinitely.
Conclusion
We report the first case of primary clear cell sarcoma of
humerus. Our findings in this report point out that pri-
mary clear cell sarcoma can originate from within the
humerus and that limb salvage surgery can achieve good
results.
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